Improving Olympic performance with asthma drugs?

A study looks at the performance benefits delivered by asthma drugs when they're taken by athletes who don't have asthma.

Improving Olympic performance with asthma drugs?
Image source: sumroeng chinnapan/Shutterstock
  • One on hand, the most common health condition among Olympic athletes is asthma. On the other, asthmatic athletes regularly outperform their non-asthmatic counterparts.
  • A new study assesses the performance-enhancement effects of asthma medication for non-asthmatics.
  • The analysis looks at the effects of both allowed and banned asthma medications.


The most common chronic disease among athletes competing in the Olympic Games is asthma. It's not a coincidence — asthma is a risk associated with activities that require increased ventilation, such as high-performance athletics. One treatment for the condition is the inhalation of β-agonists prior to exercise as a means of warding off asthma symptoms. The drugs relax the airways that provide oxygen to the lungs.

But β-agonists pose a problem for World Anti-Doping Agency (WADA) officials — drugs have been tied to performance enhancement. In fact, asthmatic athletes, who have a sound medical reason to use β-agonists, have consistently outperformed non-asthmatic athletes at the Games. There has been unconfirmed speculation that athletes who don't have asthma may also be taking β-agonists in hopes of gaining their own performance boost.

A new study published in British Journal of Sports Medicine seeks to be the most comprehensive look yet at the effect of β-agonists on athletic performance, looking at a broad selection of β-agonist drugs, including medications both allowed and banned by the WADA.

WADA uncertainty

urine sample for drug test

Image source: joel bubble ben/Shutterstock

When inhaled β-agonists first came out just before the 1972 Olympics, they were immediately banned altogether by the WADA as possible doping substances. Over the years, the WADA has reexamined their use and refined the organization's stance, evidence of the thorniness of finding an equitable position regarding their use. As of January 2020, only three β-agonists are allowed — salbutamol, formoterol, and salmeterol —and only in inhaled form. Oral consumption appears to have a greater effect on performance.

The study

runner at starting position on track

Image source: MinDof/Shutterstock

Of primary interest to the authors of the study is confirming and measuring the performance improvement to be gained from β-agonists when they're ingested by athletes who don't have asthma.

The researchers performed a meta-analysis of 34 existing studies documenting 44 randomized trials reporting on 472 participants. The pool of individuals included was broad, encompassing both untrained and elite athletes. In addition, lab tests, as opposed to actual competitions, tracked performance. The authors of the study therefore recommend taking its conclusions with just a grain of salt.

The effects of both WADA-banned and approved β-agonists were assessed.

Approved β-agonists and non-asthmatic athletes

vaulter clearing pole

Image source: Andrey Yurlov/Shutterstock

What the meta-analysis showed is that the currently approved β-agonists didn't significantly improve athletic performance among those without asthma — what very slight benefit they may produce is just enough to prompt the study's authors to write that "it is still uncertain whether approved doses improve anaerobic performance." They note that the tiny effect did increase slightly over multiple weeks of β-agonist intake.

Banned β-agonist and non-asthmatic athletes

swimmer mid stroke

Image source: Nejron Photo/Shutterstock

The study found that for athletes without asthma, however, the use of currently banned β-agonists did indeed result in enhanced performance. The authors write, "Our meta-analysis shows that β2-agonists improve anaerobic performance by 5%, an improvement that would change the outcome of most athletic competitions."

That 5 percent is an average: 70-meter sprint performance was improved by 3 percent, while strength performance, MVC (maximal voluntary contraction), was improved by 6 percent.

The analysis also revealed that different results were produced by different methods of ingestion. The percentages cited above were seen when a β-agonist was ingested orally. The effect was less pronounced when the banned substances were inhaled.

Given the difference between the results for allowed and banned β-agonists, the study's conclusions suggest that the WADA has it about right, at least in terms of selection of allowable β-agonists, as well as the allowable dosage method.

Takeaway

The study, say its authors, "should be of interest to WADA and anyone who is interested in equal opportunities in competitive sports." Its results clearly support vigilance, with the report concluding: "The use of β2-agonists in athletes should be regulated and limited to those with an asthma diagnosis documented with objective tests."


Live on Monday: Does the US need one billion people?

What would happen if you tripled the US population? Join Matthew Yglesias and Charles Duhigg at 1pm ET on Monday, September 28.

‘Time is elastic’: Why time passes faster atop a mountain than at sea level

The idea of 'absolute time' is an illusion. Physics and subjective experience reveal why.

ESA
Surprising Science
  • Since Einstein posited his theory of general relativity, we've understood that gravity has the power to warp space and time.
  • This "time dilation" effect occurs even at small levels.
  • Outside of physics, we experience distortions in how we perceive time — sometimes to a startling extent.
Keep reading Show less

Learn innovation with 3-star Michelin chef Dominique Crenn

Dominique Crenn, the only female chef in America with three Michelin stars, joins Big Think Live.

Big Think LIVE

Having been exposed to mavericks in the French culinary world at a young age, three-star Michelin chef Dominique Crenn made it her mission to cook in a way that is not only delicious and elegant, but also expressive, memorable, and true to her experience.

Keep reading Show less

Universe works like a cosmological neural network, argues new paper

Controversial physics theory says reality around us behaves like a computer neural network.

Synapses in space.

Credit: sakkmesterke
Surprising Science
  • Physicist proposes that the universe behaves like an artificial neural network.
  • The scientist's new paper seeks to reconcile classical physics and quantum mechanics.
  • The theory claims that natural selection produces both atoms and "observers".
Keep reading Show less

We studied what happens when guys add their cats to their dating app profiles

43% of people think they can get a sense of someone's personality by their picture.

Photo by Luigi Pozzoli on Unsplash
Sex & Relationships

If you've used a dating app, you'll know the importance of choosing good profile pics.

Keep reading Show less
Coronavirus

Quarantine rule breakers in 17th-century Italy partied all night – and some clergy condemned the feasting

17th-century outbreaks of plague in Italy reveal both tensions between religious and public health authorities.

Scroll down to load more…
Quantcast